PRV UL4 is a promotor of NLRP3 inflammasome Activation. حسب Xiaohua Zhang (350570)

الموضوعات:

Bar chart of state-wise annual temperature shift. حسب MD. Nahid Hassan Nishan (22264861)

الموضوعات:

Demographic characteristics of the participants. حسب MD. Nahid Hassan Nishan (22264861)

الموضوعات:

Data for Fig 6D. حسب Xiaohua Zhang (350570)

الموضوعات:

PRV UL4 also promotes AIM2-inflammasome activation. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Fig 5D. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Figs 8A–8H, 9A–9K, 10A–10I. حسب Xiaohua Zhang (350570)

الموضوعات:

Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. حسب Jelena Filimonovic (22305307)

الموضوعات:

Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019). حسب Juan Carlos Orengo (21546581)

الموضوعات:

Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. حسب Haiwei Li (282229)

الموضوعات:

Multivariate logistic regression analysis on the risk factors associated with prolonged APTT. حسب Huan Wang (109286)

الموضوعات:

Sociodemographic, occupational, and clinical risk factors associated with low workability and results of Logistic regression analysis among diabetic workers. حسب Sarah A. Bolbol (21702891)

الموضوعات:

Initial participants by wave*. حسب Yeo Ju Sohn (18536198)

الموضوعات:

General characteristics of research participants. حسب Yeo Ju Sohn (18536198)

الموضوعات:

Patient demographics. حسب Katrine Carlsen (5477300)

الموضوعات:

Changes in alpha diversity in the weeks before anti-TNF-a treatment. حسب Katrine Carlsen (5477300)

الموضوعات:

Alpha diversity measures across all 727 samples. حسب Katrine Carlsen (5477300)

الموضوعات:

Summary statistics for analysis of single genera clades. حسب Katrine Carlsen (5477300)

الموضوعات:

Abundance of the top 20 most abundant genera in one patient (Patient 1), across the weeks running up to treatment. حسب Katrine Carlsen (5477300)

الموضوعات:

Development of alpha diversity across weeks towards a new TNF treatment for each IBD disease subtype. حسب Katrine Carlsen (5477300)

الموضوعات: